11:53 AM EST - Telesta Therapeutics Inc. : Announced that it has executed a binding Agreement, subject to shareholder approval, to be acquired by ProMetic Life Sciences Inc. for consideration of $0.14/Telesta share, payable in freely tradable shares of ProMetic Life Sciences. Telesta Therapeutics Inc.
shares T.TST are trading up $0.065 at $0.14.
